Loading
This study tests TROP-2-directed treatment; the registry reports that it is recruiting.
The registry lists NCT05969041 as recruiting, last updated 2024-01-18. Enrolment is 48 planned participants, an estimate. Interventions: MT-302 (A). Primary measures include To evaluate the safety and tolerability of MT-302 through incidence of Adverse Events; To establish the maximum tolerated dose (MTD). No results are posted in the registry; this does not exclude separate publications.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/